Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
Taj Logo
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
  HOME >> PRODUCTS >> Generic Medicines >> Taj Generics >> Page 8 >> CEFOTAXIME  INJECTION



Indications and Usage :
Treatment of infections of lower respiratory tract including pneumonia, urinary tract, skin and skin structures, bone and joints; treatment of bacteremia/septicemia, CNS infections, intra-abdominal infections including peritonitis, gynecological infections including pelvic inflammatory disease, endometritis and pelvic cellulitis caused by susceptible strains of specific microorganisms; perioperative prophylaxis.

      For more information, please see Full Prescribing Information.

Contraindications :
Hypersensitivity to cephalosporins.

Dosage and Administration  :

IV/IM Up to 12 g/day in divided doses (from every 4 h for septicemia to every 12 h for uncomplicated infection) usually for 7 to 10 days. IV route is preferable for severe infections.

Children 1 mo to 12 yr of age (weighing less than 50 kg)

IV/IM 50 to 180 mg/kg/day in 4 to 6 divided doses.

Children 1 mo to 12 yr of age (weighing more than 50 kg)

Usual adult dose (max, 12 g/day).

Infants 1 to 4 wk of age

IV 50 mg/kg every 8 h.

Newborns younger than 1 wk of age

IV 50 mg/kg every 12 h.

Gonococcal Urethritis/Cervicitis in Men and Women
IM 0.5 g as single dose.

Rectal Gonorrhea

IM 0.5 g as single dose (women); 1 g as single dose (men).

Perioperative Prophylaxis

IV/IM 1 g 30 to 90 min prior to surgery.

Cesarean Section

IV 1 g as soon as umbilical cord is clamped; second and third dose IV/IM at 6- and 12-h intervals after first dose.

Dosage Adjustment for Renal Function Impairment

Reduce dose 50% in patients with Ccr less than 20 mL/min.

General Advice :
* For IM or IV administration only. Not for intradermal, subcutaneous, or intra-arterial administration.
* IV route preferred for severe or life-threatening infections, or for patients who may be poor risks because of lowered resistance.
* Follow manufacturer's guidelines for reconstitution of sterile powder with respect to diluent volume, withdrawable volume, and approximate final concentration.
* For IM administration, reconstitute vials with sterile water for injection or bacteriostatic water for injection.
* For IV administration, reconstitute vials with at least 10 mL sterile water for injection; reconstitute infusion bottles with 50 or 100 mL sodium chloride 0.9% injection or dextrose 5% injection.
* Shake to dissolve.
* Thaw premixed frozen injection at room temperature or under refrigeration (at or below 41F). Do not force thaw by immersion in water baths or microwave irradiation. Check container for minute leaks by squeezing container firmly. Discard container if leaks are detected. Do not use plastic containers in series connections because of risk of air embolism.
* Reconstituted or thawed solution should be clear and pale to light yellow in color. Do not use if discolored, cloudy, or contains particulate matter.
* Intermittent IV administration: solution containing 1 or 2 g cefotaxime in 10 mL sterile water for injection can be injected over a period of 3 to 5 min. Do not administer over a period of less than 3 min. Can also be administered via infusion system over longer period of time; temporarily discontinue administration of other solutions at same site during infusion of cefotaxime.
* For continuous IV infusion, add solution of cefotaxime to IV bottles containing compatible fluids (sodium chloride 0.9% injection, dextrose 5% or 10% injection, dextrose 5% and sodium chloride 0.9%, 0.45%, or 0.2% injection, Ringer's lactate solution, sodium lactate injection, invert sugar 10% solution, Travasol 8.5% amino acid injection without electrolytes.
* For IM administration. Dose of 2 g may be given if dose is divided and administered at different sites.

Storage/Stability :
Store vials and bottles of dry powder below 86F. Protect from light and excessive temperature. Refer to manufacturer's guidelines for storage and stability recommendations for reconstituted solutions. Store premixed frozen injection in freezer capable of maintaining temperature of −4F. Thawed solution is stable for 10 days under refrigeration (at or below 41F) or 24 h at or below 72F. Do not refreeze thawed antibiotics.


product enquiry product quotation sample request order now
Product Enquiry Product Quotation Sample Request Order Now
   Information about Generic Medicines   career
   Information about Manufacturing   career


Pharmaceuticals Generics
  Albendazole Tablets  
  Nandrolone Decanoate Injection BP, 200 mg/ml, Amp  
  Ranitidine Injection  
  Testosterone Propionate Injection  



 Print page   Send by mail








  Cefotaxime sodium injection Cefotaxime sodium injection manufacturer (Generics) exporter Cefotaxime sodium injection manufacturing composition drugs importer generic medicines Cefotaxime sodium injection Capsules Injections api association processes possibilities absorption supplier metabolism injection exporter Method preparing Cefotaxime sodium injection manufacturing Taj Pharmaceuticals Ltd. Cefotaxime sodium injection Cefotaxime sodium injection manufacturer India Exporter India Cefotaxime sodium injection Capsules Injections Gelatin Cefotaxime sodium injection BP 50mg Cefotaxime sodium injection Cefotaxime sodium injection India manufacturer exporter Cefotaxime sodium injection Capsules Injections Trading supplier export import trader Generic drugs Cefotaxime sodium injection Cefotaxime sodium injection India manufacturer exporter Cefotaxime sodium injection Capsules Injections Trading supplier export import trader Generic drugs Manufacturer manufacturing possibilities active ingredients medicine health uses trials Cefotaxime sodium injection manufacturing process Cefotaxime sodium injection possilibities India trading Cefotaxime sodium injection supplier supply suppliers vendor vendors price prices Cefotaxime sodium injection  
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
















About Taj


Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors


Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement